Corona Remedies IPO: Day 1 Subscription, Price Band & Key Details Explained
The buzz around the Corona Remedies IPO has been building steadily—and Day 1 of the public issue has only amplified the interest. As the pharma company opens its ₹655.37 crore public offer, investors across the retail, QIB, and NII segments are tuning in to understand what the issue looks like, w...
Easy & quick